Cargando…

Complete resistance after maximal dose of rocuronium

Rocuronium is a non-depolarizing neuromuscular blocking agent (NDNMBA), employed in the clinic as an adjunct to general anesthesia to facilitate tracheal intubation rapid sequence, and to provide skeletal muscle relaxation during surgery. Many cases of resistance to neuromuscular blocking agents (NM...

Descripción completa

Detalles Bibliográficos
Autores principales:	Capuano, Annalisa, Sullo, Maria Giuseppa, Rafaniello, Concetta, Sportiello, Liberata, Fusco, Pierfrancesco, De Vizia, Macella, Ferraro, Fausto
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2015
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4544144/ https://www.ncbi.nlm.nih.gov/pubmed/26312006 http://dx.doi.org/10.4103/0976-500X.162012

Ejemplares similares

Erratum: Complete resistance after maximal dose of rocuronium
Publicado: (2015)

Drugs-Induced Pathological Gambling: An Analysis of Italian Spontaneous Reporting System
por: Scavone, Cristina, et al.
Publicado: (2019)

Pattern of Statin Use in Southern Italian Primary Care: Can Prescription Databases Be Used for Monitoring Long-Term Adherence to the Treatment?
por: Ferrajolo, Carmen, et al.
Publicado: (2014)

Quinolones-Induced Musculoskeletal, Neurological, and Psychiatric ADRs: A Pharmacovigilance Study Based on Data From the Italian Spontaneous Reporting System
por: Scavone, Cristina, et al.
Publicado: (2020)

Pillars and Pitfalls of the New Pharmacovigilance Legislation: Consequences for the Identification of Adverse Drug Reactions Deriving From Abuse, Misuse, Overdose, Occupational Exposure, and Medication Errors
por: Sessa, Maurizio, et al.
Publicado: (2018)

Preventable Cases of Oral Anticoagulant-Induced Bleeding: Data From the Spontaneous Reporting System
por: Mascolo, Annamaria, et al.
Publicado: (2019)

Hypoglycemia, polycythemia and hyponatremia in a newborn exposed to nebivolol during pregnancy
por: Sullo, Maria Giuseppa, et al.
Publicado: (2015)

Safety Profile of Anticancer and Immune-Modulating Biotech Drugs Used in a Real World Setting in Campania Region (Italy): BIO-Cam Observational Study
por: Scavone, Cristina, et al.
Publicado: (2017)

It is the time to change the paradigms of pregnant and breastfeeding women in clinical research!
por: Sportiello, Liberata, et al.
Publicado: (2023)

Campania Preventability Assessment Committee (Italy): A Focus on the Preventability of Non-steroidal Anti-inflammatory Drugs' Adverse Drug Reactions
por: Sessa, Maurizio, et al.
Publicado: (2017)

Safety profile of sodium glucose co-transporter 2 (SGLT2) inhibitors: A brief summary
por: Mascolo, Annamaria, et al.
Publicado: (2022)

Did the New Italian Law on Mandatory Vaccines Affect Adverse Event Following Immunization’s Reporting? A Pharmacovigilance Study in Southern Italy
por: Scavone, Cristina, et al.
Publicado: (2018)

Current pharmacological treatments for COVID‐19: What's next?
por: Scavone, Cristina, et al.
Publicado: (2020)

Capillary leak syndrome following COVID-19 vaccination: Data from the European pharmacovigilance database Eudravigilance
por: Ruggiero, Rosanna, et al.
Publicado: (2022)

PCSK9 Inhibitors and Neurocognitive Adverse Drug Reactions: Analysis of Individual Case Safety Reports from the Eudravigilance Database
por: di Mauro, Gabriella, et al.
Publicado: (2020)

Tisagenlecleucel in Children and Young Adults: Reverse Translational Research by Using Real-World Safety Data
por: Rafaniello, Concetta, et al.
Publicado: (2020)

Immune Checkpoint Inhibitors and Immune-Related Adverse Drug Reactions: Data From Italian Pharmacovigilance Database
por: Ruggiero, Rosanna, et al.
Publicado: (2020)

We Really Need Clear Guidelines and Recommendations for Safer and Proper Use of Aripiprazole and Risperidone in a Pediatric Population: Real-World Analysis of EudraVigilance Database
por: Rafaniello, Concetta, et al.
Publicado: (2020)

Cardiac Events Potentially Associated to Remdesivir: An Analysis from the European Spontaneous Adverse Event Reporting System
por: Rafaniello, Concetta, et al.
Publicado: (2021)

Disentangling a Thorny Issue: Myocarditis and Pericarditis Post COVID-19 and Following mRNA COVID-19 Vaccines
por: Rafaniello, Concetta, et al.
Publicado: (2022)

Did the COVID-19 Pandemic Affect Contrast Media-Induced Adverse Drug Reaction’s Reporting? A Pharmacovigilance Study in Southern Italy
por: Rossi, Claudia, et al.
Publicado: (2022)

Beta-blocker choice and exchangeability in patients with heart failure and chronic obstructive pulmonary disease: an Italian register-based cohort study
por: Sessa, Maurizio, et al.
Publicado: (2019)

Therapeutic strategies to fight COVID‐19: Which is the status artis?
por: Scavone, Cristina, et al.
Publicado: (2021)

Neurological Manifestations Related to Immune Checkpoint Inhibitors: Reverse Translational Research by Using the European Real-World Safety Data
por: Ruggiero, Rosanna, et al.
Publicado: (2022)

Risk of acute and serious liver injury associated to nimesulide and other NSAIDs: data from drug‐induced liver injury case–control study in Italy
por: Donati, Monia, et al.
Publicado: (2016)

Dipeptidyl peptidase-4 inhibitors in type 2 diabetes therapy – focus on alogliptin
por: Capuano, Annalisa, et al.
Publicado: (2013)

Contrast media-induced nephropathy: how has Italy contributed in the past 30 years? A systematic review
por: Sessa, Maurizio, et al.
Publicado: (2017)

Gut-Brain Axis in Gastric Mucosal Damage and Protection
por: Sgambato, Dolores, et al.
Publicado: (2016)

SARS-Cov-2 infection: Response of human immune system and possible implications for the rapid test and treatment
por: di Mauro, Gabriella, et al.
Publicado: (2020)

Repeat dosing of rocuronium-sugammadex: unpredictable
por: Kim, Yoon-Hee
Publicado: (2014)

Comparison of equipotent doses of rocuronium and vecuronium
por: Parasa, Mrunalini, et al.
Publicado: (2015)

Maternal, fetal and neonatal outcomes among pregnant women receiving COVID-19 vaccination: The preg-co-vax study
por: Mascolo, Annamaria, et al.
Publicado: (2022)

Which is the top player for the cardiovascular safety? ibrutinib vs. obinutuzumab in CLL
por: Mascolo, Annamaria, et al.
Publicado: (2023)

Thromboembolic Events after COVID-19 Vaccination: An Italian Retrospective Real-World Safety Study
por: Bernardi, Francesca Futura, et al.
Publicado: (2023)

Disease-Modifying Therapies (DMTs) in Pregnant and Lactating Women with Multiple Sclerosis: Analysis of Real-World Data from EudraVigilance Database
por: Sportiello, Liberata, et al.
Publicado: (2023)

Effects of rocuronium, sugammadex and rocuronium-sugammadex complex on coagulation in rats
por: Lima Cavalcanti, Ismar, et al.
Publicado: (2020)

The Pharmacological Treatment of Chronic Pain: From Guidelines to Daily Clinical Practice
por: Marcianò, Gianmarco, et al.
Publicado: (2023)

‘Jaws of steel’ after rocuronium
por: Raut, Monish S, et al.
Publicado: (2016)

Safety Monitoring of mRNA COVID-19 Vaccines in Children Aged 5 to 11 Years by Using EudraVigilance Pharmacovigilance Database: The CoVaxChild Study
por: Zinzi, Alessia, et al.
Publicado: (2023)

The Effect of Patient Weight and Provider Training and Experience on Dosing of Rocuronium
por: Godwin, N. C., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_4vt4k16kfng3lpi1mevgd7vu0s